Standout Papers
Citation Impact
Citing Papers
α‐Tocopherol mediated peroxidation in the copper (II) and met myoglobininduced oxidation of human low density lipoprotein: The influence of lipid hydroperoxides
1995
[43] Malondialdehyde determination as index of lipid Peroxidation
1990 Standout
Metagenomic Analysis of the Human Distal Gut Microbiome
2006 StandoutScience
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1
2007 StandoutNobel
The ambivalence of vitamin E in atherogenesis
1999
Antioxidant and prooxidant activity of alpha-tocopherol in human plasma and low density lipoprotein.
1996
The lipid peroxidation product 4-hydroxy-2-nonenal: Advances in chemistry and analysis
2013
Lipid hydroperoxide generation, turnover, and effector action in biological systems
1998
Comparison between copper-mediated and hypochlorite-mediated modifications of human low density lipoproteins evaluated by protein carbonyl formation
1997
Hypoxia and intra-complex genetic suppressors rescue complex I mutants by a shared mechanism
2024 StandoutNobel
Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesions
2000
Vitamin E supplementation suppresses indexes of lipid peroxidation and platelet counts in blood of smokers and nonsmokers but plasma lipoprotein concentrations remain unchanged
1994
Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
1998 StandoutNature
Relationship of electrophilic stress to aging
2011
Rabbit Serum Paraoxonase 3 (PON3) Is a High Density Lipoprotein-associated Lactonase and Protects Low Density Lipoprotein against Oxidation
2000
Inhibition of Class-3 aldehyde dehydrogenase and cell growth by restored lipid peroxidation in hepatoma cell lines
1999
Beyond alcohol: Beverage consumption and cardiovascular mortality
1995
Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation.
1995
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Plasma copper and lipid peroxidation in cigarette smokers
1995
Circulating mitochondrial DAMPs cause inflammatory responses to injury
2010 StandoutNature
Molecular Chlorine Generated by the Myeloperoxidase-Hydrogen Peroxide-Chloride System of Phagocytes Converts Low Density Lipoprotein Cholesterol into a Family of Chlorinated Sterols
1996
Ceruloplasmin Enhances Smooth Muscle Cell- and Endothelial Cell-mediated Low Density Lipoprotein Oxidation by a Superoxide-dependent Mechanism
1996
Inflammation and metabolic disorders
2006 StandoutNature
Oxidative damage to DNA: Formation, measurement, and biological significance
1997
Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways
2003
Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heart
2011
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
2000 StandoutNature
Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro
1999
Vitamin E in Humans: Demand and Delivery
1996
4-Hydroxynonenal–protein adducts: A reliable biomarker of lipid oxidation in liver diseases
2007
Intracellular metabolism of 4-hydroxynonenal
2003
The role of vitamin E in atherosclerosis
2003
Secretory Sphingomyelinase, a Product of the Acid Sphingomyelinase Gene, Can Hydrolyze Atherogenic Lipoproteins at Neutral pH
1998
Increased oxidative stress in obesity and its impact on metabolic syndrome
2004 Standout
The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity
1996
Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both
1999
Intact human ceruloplasmin oxidatively modifies low density lipoprotein.
1994
Biomarkers of lipid peroxidation in clinical material
2013
Glutathione conjugates of 4-hydroxy-2(E)-nonenal as biomarkers of hepatic oxidative stress-induced lipid peroxidation in rats
2005
Dietary and pharmacological antioxidants in atherosclerosis
1999
Metabolism of 4‐hydroxynonenal by the rat heptoma cell line MH1C1
1988
Autophagy regulates lipid metabolism
2009 StandoutNature
Cell death and diseases related to oxidative stress:4-hydroxynonenal (HNE) in the balance
2013
Nonalcoholic Fatty Liver Disease
2002 Standout
Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis
1996
Oxidative Modification and Nitration of Human Low-Density Lipoproteins by the Reaction of Hypochlorous Acid with Nitrite
1997
Structure and function of glutathione S-transferases
1994
The toxicity to macrophages of oxidized low-density lipoprotein is mediated through lysosomal damage
1997
How to Characterize a Biological Antioxidant
1990
p-Hydroxyphenylacetaldehyde, the Major Product of l-Tyrosine Oxidation by the Myeloperoxidase-H2O2-Chloride System of Phagocytes, Covalently Modifies ε-Amino Groups of Protein Lysine Residues
1997
Binding of iron(II) ions to the pentose sugar 2-deoxyribose
1989
Possible mutagens derived from lipids and lipid precursors
1990
“In vitro” effect of cumene hydroperoxide on hepatic elongation factor-2 and its protection by melatonin
2003
Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase
1993 Standout
4‐Hydroxynonenal: A membrane lipid oxidation product of medicinal interest
2007
Continuous Monitoring ofin VztroOxidation of Human Low Density Lipoprotein
1989 Standout
Lipid peroxidation and neurodegenerative disease
2011
Alcohol-induced oxidative stress
2007
p-Hydroxyphenylacetaldehyde, an Aldehyde Generated by Myeloperoxidase, Modifies Phospholipid Amino Groups of Low Density Lipoprotein in Human Atherosclerotic Intima
2000
3-Hydroxyanthranilic Acid Is an Efficient, Cell-derived Co-antioxidant for α-Tocopherol, Inhibiting Human Low Density Lipoprotein and Plasma Lipid Peroxidation
1996
3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.
1997 Standout
Genotoxicity of HNE
2003
Effect of dietary catechin and vitamin E on aortic fatty streak accumulation in hypercholesterolemic hamsters
1998
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
2009 StandoutNature
Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid–protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins
1999
Requirement for, Promotion, or Inhibition by α-Tocopherol of Radical-Induced Initiation of Plasma Lipoprotein Lipid Peroxidation
1997
Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders
2009
Activation of phosphoinositide‐specific phospholipase C of rat neutrophils by the chemotactic aldehydes 4‐hydroxy‐2,3‐trans‐nonenal and 4‐hydroxy‐2,3‐trans‐octenal
1994
The mechanosensory protein MEC-6 is a subunit of the C. elegans touch-cell degenerin channel
2002 StandoutNatureNobel
Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts
1998
Aortic antioxidant defence mechanisms: time-related changes in cholesterol-fed rabbits
1990
Role of reactive aldehyde in cardiovascular diseases
2000
Immunohistochemical Characterization of Hepatic Malondialdehyde and 4-Hydroxynonenal Modified Proteins During Early Stages of Ethanol-Induced Liver Injury
2003
Structure-antioxidant activity relationships of flavonoids and phenolic acids
1996 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Regulation of Rat Hepatocyte Protein Kinase C β Isoenzymes by the Lipid Peroxidation Product 4–Hydroxy–2,3–Nonenal: A Signaling Pathway to Modulate Vesicular Transport of Glycoproteins
1999
Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.
1995
Self-regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death
2008
Resveratrol: A molecule whose time has come? And gone?
1997 Standout
Beyond LDL oxidation: ROS in vascular signal transduction
2003
Myeloperoxidase binds to low‐density lipoprotein: potential implications for atherosclerosis
2000
4-Hydroxynonenal formation during ischemia and reperfusion of rat small intestine
1995
The antioxidant properties of theaflavins and their gallate esters — radical scavengers or metal chelators?
1996
Modification of human serum low density lipoprotein by oxidation — Characterization and pathophysiological implications
1987
Inverse deuterium kinetic isotope effect for peroxidation in human low‐density lipoprotein (LDL): a simple test for tocopherol‐mediated peroxidation of LDL lipids
1995
Genome maintenance mechanisms for preventing cancer
2001 StandoutNature
Transient reduction of autoantibodies against oxidized ldl in patients with acute myocardial infarction
1995
Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro.
1994
Oxidants, oxidative stress and the biology of ageing
2000 StandoutNature
Identification of the haemoglobin scavenger receptor
2001 StandoutNature
Plasma and LDL Levels of Major Lipophilic Antioxidants are Similar in Patients with Advanced Atherosclerosis and Age-Matched Controls
1997
4-hydroxynonenal and regulation of cell cycle: effects on the pRb/E2F pathway
2004
Atherosclerosis — An Inflammatory Disease
1999 Standout
Activation of PKC-β isoforms mediates HNE-induced MCP-1 release by macrophages
2002
4-Hydroxynonenal Induces G2/M Phase Cell Cycle Arrest by Activation of the Ataxia Telangiectasia Mutated and Rad3-related Protein (ATR)/Checkpoint Kinase 1 (Chk1) Signaling Pathway
2013
Interaction Between Neutrophils and 4-Hydroxyalkenals and Consequences on Neutrophil Motility
1988
Reactive oxygen species have a causal role in multiple forms of insulin resistance
2006 StandoutNature
4-Hydroxynonenal and neurodegenerative diseases
2003
Nitrogen dioxide radical generated by the myeloperoxidase‐hydrogen peroxide‐nitrite system promotes lipid peroxidation of low density lipoprotein
1999
HNE interacts directly with JNK isoforms in human hepatic stellate cells.
1998
Recent Advances in the Development of a Diagnostic Test for Irradiated Foodstuffs
1989
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury
1990 Standout
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
2000
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
(E)-4-Hydroxy-2-Nonenal May be Involved in the Pathogenesis of Parkinson’s Disease
1998
Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in men
2005
Interactions of glutathione transferases with 4-hydroxynonenal
2011
Gastrointestinal glutathione peroxidase prevents transport of lipid hydroperoxides in CaCo-2 cells
2000
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
2019 StandoutNature
Reactions of 4-hydroxynonenal with proteins and cellular targets
2004
The role of oxidized lipoproteins in atherogenesis
1996
Effects of 4-hydroxynonenal on vascular endothelial and smooth muscle cell redox signaling and function in health and disease
2013
Atherosclerosis
2000 StandoutNature
Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo
1997
Antioxidant activities of carotenes and xanthophylls
1996
Depletion of Alpha-Tocopherol in Human Atherosclerotic Lesions
1995
Invited Commentary Potential Contribution of the Glutathione S-Transferase Supergene Family to Resistance to Oxidative Stress
1995
Sirtuin activators mimic caloric restriction and delay ageing in metazoans
2004 StandoutNature
On the stimulation of soluble and particulate guanylate cyclase in the rat brain and the involvement of nitric oxide as studied by cGMP immunocytochemistry
1992
Human neutrophils employ chlorine gas as an oxidant during phagocytosis.
1996
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
2003 StandoutNature
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
2010 StandoutNature
Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
1998 Standout
Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.
1996
Repair kinetics of acrolein- and (E)-4-hydroxy-2-nonenal-derived DNA adducts in human colon cell extracts
2013
Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein
1991 Standout
Modulation of keratinocyte expression of antioxidants by 4-hydroxynonenal, a lipid peroxidation end product
2014
Experimental researches on the role of phosphoinositide‐specific phospholipase C in 4‐hydroxynonenal induced exocytosis
2003
α-Tocopherol as a Reductant for Cu(II) in Human Lipoproteins
1996
Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans
1999
Comparison of the effects of α-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbits
2002
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
1991 Standout
α‐Tocopherol does not inhibit hypochlorite‐induced oxidation of apolipoprotein B‐100 of low‐density lipoprotein
1997
Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in women
2004
Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation
1994 StandoutNatureNobel
Direct Copper Reduction by Macrophages
1997
Antioxidant activity applying an improved ABTS radical cation decolorization assay
1999 Standout
Peroxynitrite modification of low‐density lipoprotein leads to recognition by the macrophage scavenger receptor
1993
Can antioxidant vitamins materially reduce oxidative damage in humans?
1999
4-Hydroxy-2-Nonenal, a Reactive Product of Lipid Peroxidation, and Neurodegenerative Diseases: A Toxic Combination Illuminated by Redox Proteomics Studies
2011
Serum 4-Hydroxy-2-Nonenal-Modified Albumin Is Elevated in Patients with Type 2 Diabetes Mellitus
2000
Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage
1999 StandoutNobel
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits.
1993
Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids
1980
Protein Oxidation and Aging
1992 StandoutScience
Vitamin C protects against and reverses specific hypochlorous acid- and chloramine-dependent modifications of low-density lipoprotein
2000
Increased uptake of α-hydroxy aldehyde-modified low density lipoprotein by macrophage scavenger receptors
2000
Involvement of 15-lipoxygenase in early stages of atherogenesis.
1994
Both Intracellular and Extracellular Vitamin C Inhibit Atherogenic Modification of LDL by Human Vascular Endothelial Cells
1997
Mass spectrometric quantification of amino acid oxidation products in proteins: insights into pathways that promote LDL oxidation in the human artery wall
1999
Antioxidant properties of phenolic compounds
1997 Standout
The importance of free radicals and catalytic metal ions in human diseases
1985
Site-Specific Antiatherogenic Effect of Probucol in Apolipoprotein E–Deficient Mice
2000
HPLC Analysis of Lipid-derived Polyunsaturated Fatty Acid Peroxidation Products in Oxidatively Modified Human Plasma
2000
The "Two-Faced" Effects of Reactive Oxygen Species and the Lipid Peroxidation Product 4-Hydroxynonenal in the Hallmarks of Cancer
2010
Mechanisms of DNA Excision Repair
1994 StandoutScienceNobel
Is oxidized low‐density lipoprotein present in vivo?
1998
Contribution of an In Vivo Oxidized LDL to LDL Oxidation and Its Association With Dense LDL Subpopulations
1996
[1] Role of free radicals and catalytic metal ions in human disease: An overview
1990 Standout
Studies on the mechanism of formation of 4-hydroxynonenal during microsomal lipid peroxidation
1986
Tocopherol‐mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement
1999
Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages
1998
Prostaglandin F2-Like Compounds, F2-Isoprostanes, Are Present in Increased Amounts in Human Atherosclerotic Lesions
1997
Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels
2002
Oxidative Stress, Caloric Restriction, and Aging
1996 StandoutScience
Time-dependent changes to lipids and antioxidants in plasma and aortas of apolipoprotein E knockout mice
1999
Fatty Streak Formation in Fat-Fed Mice Expressing Human Copper-Zinc Superoxide Dismutase
1997
Association of Serum Vitamin Levels, LDL Susceptibility to Oxidation, and Autoantibodies Against MDA-LDL With Carotid Atherosclerosis
1997
Recognition of oxidatively damaged erythrocytes by a macrophage receptor with specificity for oxidized low density lipoprotein.
1994
Cytotoxic aldehydes originating from the peroxidation of liver microsomal lipids
1984
Human Serum Paraoxonases (PON1) Q and R Selectively Decrease Lipid Peroxides in Human Coronary and Carotid Atherosclerotic Lesions
2000 Standout
Mitochondrial Diseases in Man and Mouse
1999 StandoutScience
The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease
1995
Immunohistochemical Characterization of Hepatic Malondialdehyde and 4‐Hydroxynonenal Modified Proteins During Early Stages of Ethanol‐Induced Liver Injury
2003
Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content.
1994
Human Atherosclerotic Plaque Contains Both Oxidized Lipids and Relatively Large Amounts of α-Tocopherol and Ascorbate
1995
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
1996 StandoutScience
Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation
1994
Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells.
1992
Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls
1996
Glutathione-Related Antioxidant Defenses in Human Atherosclerotic Plaques
1998
Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes
1997 StandoutScience
Cytotoxicity, DNA fragmentation and sister-chromatid exchange in Chinese hamster ovary cells exposed to the lipid peroxidation product 4-hydroxynonenal and homologous aldehydes
1986
Expression cloning of SR-BI, a CD36-related class B scavenger receptor.
1994
Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein.
1994
Detection of 4-hydroxynonenal as a product of lipid peroxidation in native ehrlich ascites tumor cells
1984
Cytotoxicity and metabolism of 4-hydroxy-2-nonenal and 2-nonenal in H2O2-resistant cell lines. Do aldehydic by-products of lipid peroxidation contribute to oxidative stress?
1990 StandoutNobel
Cytokine Modulation of LDL Oxidation by Activated Human Monocytes
1997
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Patients With Early-Onset Peripheral Vascular Disease Have Increased Levels of Autoantibodies Against Oxidized LDL
1995
Methods for determination of aldehydic lipid peroxidation products
1989
Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes.
1993
Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene.
1993
Molecular cloning and functional expression of a human cDNA encoding the antimutator enzyme 8-hydroxyguanine-DNA glycosylase
1997 StandoutNobel
Autoxidation of polyunsaturated esters in water: chemical structure and biological activity of the products
1967
Human Neutrophils Employ Myeloperoxidase To Convert α-Amino Acids to a Battery of Reactive Aldehydes: A Pathway for Aldehyde Generation at Sites of Inflammation
1998
Coexistence of Oxidized Lipids and α-Tocopherol in All Lipoprotein Density Fractions Isolated From Advanced Human Atherosclerotic Plaques
1999
The role of oxidative damage in the neuropathology of organic acidurias: Insights from animal studies
2004
LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers.
1994
[42] Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal
1990 Standout
Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis
2010
Does vitamin C act as a pro‐oxidant under physiological conditions?
1999
Covalent Modification of Amino Acid Nucleophiles by the Lipid Peroxidation Products 4-Hydroxy-2-nonenal and 4-Oxo-2-nonenal
2002
Role of Nrf2 in the Regulation of CD36 and Stress Protein Expression in Murine Macrophages
2004
Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes
1987
Effects of the lipid peroxidation product 4-hydroxynonenal on the aggregation of human platelets
1987
Oxidation of LDL by recombinant human 15-lipoxygenase: evidence for alpha-tocopherol-dependent oxidation of esterified core and surface lipids
1996
Modification of histidine residues in proteins by reaction with 4-hydroxynonenal.
1992
Chemical Implications for Antitumor and Antiviral Prostaglandins: Reaction of Δ7-Prostaglandin A1 and Prostaglandin A1 Methyl Esters with Thiols
1997 StandoutNobel
Works of H. Esterbauer being referenced
Nitroxide reduction with ascorbic acid in spin labeled human plasma LDL and VLDL
1997
Metabolism of 4-Hydroxynonenal, a Cytotoxic Lipid Peroxidation Product, in Thymocytes as an Effective Secondary Antioxidative Defense Mechanism
1998
Human plasma lipid peroxide levels show a strong transient increase after successful revascularization operations
1992
The interaction of lower alcohols with apoB in spin labeled human plasma low density lipoproteins (LDL)
1997
Elevated serum neopterin levels in atherosclerosis
1991
Enhanced plasma level of lipid peroxidation in Iranians could be improved by antioxidants supplementation
1997
Risk factors for microangiopathy-related cerebral damage in the Austrian stroke prevention study
1997
Lipid peroxidation in human diseases: Evidence of red cell oxidative stress after circulatory shock
1989
Cumene hydroperoxide, an agent inducing lipid peroxidation, and 4-hydroxy-2,3-nonenal, a peroxidation product, cause coronary vasodilatation in perfused rat hearts by a cyclic nucleotide independent mechanism
1990
The role of lipid peroxidation and antioxidants in oxidative modification of LDL
1992 Standout
Chemotactic activity of hydroxyalkenals on rat neutrophils.
1985
�ber die Wirkungen von Aldehyden auf gesunde und maligne Zellen, 1. Mitt.: Hydroxy-octenal, ein neuer Fettaldehyd
1964
�ber die Reaktion von ?9, 12-Linols�ureester in wasser, 6. Mitt.: Chromatographische Untersuchungen �ber die Zusammensetzung des Pr�parates ?LHPO? und die Isolierung der einzelnen tumorwirksamen Hydroperoxydkomponenten
1963
Resistance to oxidative stress by hyperplastic and neoplastic rat liver tissue monitored in terms of production of unpolar and medium polar carbonyls
1986
Metabolism of 4-hydroxynonenal, a cytotoxic lipid peroxidation product, in Ehrlich mouse ascites cells at different proliferation stages.
1994
Possible role of aldehydic lipid peroxidation products as chemoattractants.
1987
Role of cardiac glutathione transferase and of the glutathione S-conjugate export system in biotransformation of 4-hydroxynonenal in the heart.
1986
Kinetik der Reaktion von Sulfhydrylverbindungen mit ?,?-unges�ttigten Aldehyden in w��rigem System
1970
Hydroxyl-radical-induced iron-catalysed degradation of 2-deoxyribose. Quantitative determination of malondialdehyde
1988
�ber die Reaktion von Protein-SH-Gruppen mit 4-Hydroxypentenal
1971
Über die Reaktion von Δ9,12-Linolsäureester in Wasser, 7. Mitt.: Präparative säulenchromatographische Isolierung der einzelnen Substanzen des Präparates “LHPO”
1963
Structure-activity relationships of 4-hydroxyalkenals in the conjugation catalysed by mammalian glutathione transferases
1987
A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent.
1989
Metabolism of the lipid peroxidation product 4-hydroxynonenal by isolated hepatocytes and by liver cytosolic fractions
1985
Neutrophil chemotactic responses to aldehydes.
1982
�ber die Wirkungen von Aldehyden auf gesunde und maligne Zellen, 2. Mitt.: Synthese von homologen 4-Hydroxy-2-alkenalen, I
1967
Effects of 4-hydroxynonenal on isolated hepatocytes. Studies on chemiluminescence response, alkane production and glutathione status
1983
Metabolic fate of 4-hydroxynonenal in hepatocytes: 1,4-dihydroxynonene is not the main product
1997
Synthese einiger 4-Hydroxy-2-alkenale
1971
Identification of metabolic pathways of the lipid peroxidation product 4-hydroxynonenal by enterocytes of rat small intestine.
1991
Effect of 4-hydroxy-2,3-trans-nonenal and related aldehydes on phospholipase C activity of rat neutrophils.
1993
Cytotoxic lipid peroxidation products.
1987